Cell manufacturing with GMP ancillary material solutions from BioLegend
Description: In this webinar, Kenta Yamamoto presents an overview of BioLegend’s comprehensive contract development and manufacturing services, highlights our GMP bioprocessing capabilities in alignment with relevant regulatory guidelines (e.g., USP <1043>), and shares project examples demonstrating how our ancillary material solutions can help advance your novel cell therapy to the clinic.
Login / Register 



Follow Us